President Biden has unveiled the first part in his two-part plan for rescue and economic recovery—the American Rescue Plan. He is expected to lay out part two – the Build Back Better Recovery Plan, next month. The $1.9 trillion American Rescue Plan is intended to address immediate COVID-19 needs, while the Build Back Better Recovery […]
Issuing a regulatory freeze is standard practice for an incoming administration, so as expected, shortly after President Biden was sworn in on January 20, the White House issued a memo directing agencies to freeze for 60 days any agency rules or guidance issued by the Trump administration that have not taken effect by Inauguration Day. […]
Following his inauguration on January 20, President Biden signed 17 executive orders — including several aimed at COVID-19 and others overturning a number of President Trump’s previous executive orders and policies. The January 20 orders included a mask mandate for all federal properties and for interstate travel, rejoining the World Health Organization, reinstating the Global […]
Calling all life sciences early stage founders and startups! In partnership with the Lassonde Entrepreneur Institute at the University of Utah, the University’s David Eccles School of Business is now accepting applications to join its Master of Business Creation (MBC) program for 2021-2022. The priority application deadline is Feb. 12, 2021. This nine-month, professional-degree program […]
Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) recently announced that the first patient has been dosed in a Phase 1/2 study evaluating the investigational agent TP-0184, an activin receptor-like kinase 2 (ALK2) and ALK5 inhibitor, for the treatment of anemia in adult patients with low or intermediate risk myelodysplastic syndromes (MDS). “The management of […]
Ready to expand your company’s visibility and partnership opportunities beyond borders in 2021? Join the Innovation Stage, BIO Digital’s new interactive forum showcasing the hottest companies in biotech! How does it work? Fast-paced presentations and networking allow you to showcase your company, biotech region, or technology to a global audience of prospective partners ahead of […]
Presented by BioUtah and the Salt Lake Chamber on January 15, 2021, this webinar provided a briefing with biopharmaceutical industry experts to discuss the science behind the development of COVID-19 vaccines, the regulatory process to ensure they’re safe and effective and an update on Utah’s participation in COVID-19 clinical trials. […]
Press Release Courtesy of Gentex ZEELAND, Mich., Jan. 12, 2021 (GLOBE NEWSWIRE) — Gentex Corporation (NASDAQ: GNTX) today announced the acquisition of a new nanofiber sensing technology capable of detecting a wide variety of chemicals, from explosives to volatile organic compounds, with widespread application in a multitude of industries. Gentex is a long-time supplier of electro-optical products for the global […]
PPP loans have been reopened with an infusion of $284 billion for First Draw and Second Draw loans. First Draw loan applications will be accepted from January 11, 2021 to March 31, 2021. Second Draw applications begin January 13, 2021, until March 31, 2021. To promote access for smaller lenders and their customers, SBA will […]
On January 14th, January 26th, and February 2nd, don’t miss this series with the United States – Mexico Chamber of Commerce on the life sciences industry. Beginning on January 14th, join the video conference on Mexico’s Economic and Political Outlook. Following that, January 26th will cover Mexico’s Pharma, Biotech and Medical Devices Sectors, and February […]
Apply to Present at BIO-Europe Spring® Digital NEW deadline to apply is January 20. View Presentation Options Attracting visibility as a presenting company has never been easier at BIO-Europe Spring Digital! While presenting at a digital event may be different than what you are used to in person, it does provide new opportunities for […]
Based on its preliminary internal financial reporting for the fourth quarter 2020, Co-Diagnostics has announced that unaudited quarterly revenue for the company is anticipated to be the highest in the company’s history and to surpass analyst estimates. Analysts’ estimates for the fourth quarter ranged from $24 million to $25.98 million. Quarterly revenue is anticipated to […]